Search for: "California v. Rivas"
Results 21 - 33
of 33
Sorted by Relevance
|
Sort by Date
10 May 2021, 3:06 pm
LE-1, a Florida Limited Liability Company d/b/a LE-1, a California Limited Partnership, Petitioner, v. [read post]
27 Oct 2021, 9:15 am
Bond, 20-1668, and Rivas-Villegas v. [read post]
3 Apr 2015, 3:26 pm
See Riva v. [read post]
9 Feb 2023, 5:01 am
Times, (Feb. 18, 2021, 4:50 PM), https://www.latimes.com/entertainment–arts/story/2021–02–18/immigration–alien–noncitizen–language–politi cs-undocumented(last visited Oct. 23, 2021). 4 Beam, Adam, California to replace the word 'alien' from its laws, Associated Press News, (Sep. 24, 2021), https://apnews.com/article/immigration–california-race-and-ethnicity-racial-injustice-gavin-newsom(last visited Oct. 23, 2021).… [read post]
30 Jan 2008, 7:35 am
Supreme Court, January 22, 2008 Ali v. [read post]
11 Nov 2021, 8:08 am
” “‘Within days’ of the Sept. 19, 2019, receipt of the fourth letter, Houston and Rivas ran it by Reed Smith’s in-house counsel and the California State Bar’s ethics hotline, the panel said. [read post]
2 Aug 2018, 10:33 am
California, 376 U.S. 483, 489-90 (1964); Chapman v. [read post]
2 Sep 2008, 5:17 pm
U.S. 1st Circuit Court of Appeals, August 27, 2008 US v. [read post]
1 Sep 2021, 3:00 am
The case and the Court’s summary is as follows: County of Butte v. [read post]
1 Sep 2021, 3:00 am
The case and the Court’s summary is as follows: County of Butte v. [read post]
15 Dec 2010, 2:43 pm
News & Analysis 10706-10712 (2010).Riva Palacio Lavín, Antonio. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007:… [read post]
